Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 135 clinical trials
featured
  • 0 views
  • 24 Jun, 2021
  • 1 location
featured
A Prospective, Randomized, Double-masked, Active Comparator-controlled, Multi-center, Two-arm, Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Visual Impairment Due to Treatment-naïve Macular Edema Secondary to Retinal Vein Occlusion (RVO)

This Phase 3 study will evaluate the efficacy, durability, and safety of KSI-301 compared to aflibercept, in participants with macular edema due to treatment-naïve branch (BRVO) or central retinal vein occlusion (CRVO).

spectral domain optical coherence tomography
aflibercept
macular edema
retinal vein occlusion
  • 0 views
  • 24 Jun, 2021
  • 1 location
Tactile Low Vision Labeling of Ophthalmic Drops

with the UTMB Maker Space to improve low vision patients capability to identify their topical ophthalmic drop treatments and the frequency with which they should be administered. The labeling strategy

  • 0 views
  • 16 Apr, 2021
  • 1 location
To Compare Brolucizumab to Aflibercept in Chinese Patients With Visual Impairment Due to Diabetic Macular Edema

The purpose of this study is to evaluate the efficacy and safety of brolucizumab in treatment of Chinese patients with visual impairment due to Diabetic Macular Edema.

aflibercept
diabetes
visual impairment
brolucizumab
type 2 diabetes mellitus
  • 0 views
  • 14 Apr, 2021
  • 15 locations
Low Vision Patients' Preference for Colored Filters and Illumination for Near Reading Determined by the LuxIQ/2

The effect of tinted filters and illumination on the visual performance of patients with low vision (i.e., individuals with reduced vision that is uncorrectable with glasses, surgery or

  • 5 views
  • 09 Mar, 2021
  • 1 location
Treating Amblyopia in Adults With Interactive Video Games

Researchers are trying to determine whether interactive video game play, while wearing a patch over better-seeing eye, will improve subject reduced vision (amblyopia).

visual impairment
anisometropic
  • 9 views
  • 27 Jan, 2021
  • 1 location
601 Versus Ranibizumab in Patients With Pathological Myopic Choroidal Neovascularization (pmCNV)

To evaluate the safety and efficacy of intravitreal recombinant humanized anti-VEGF monoclonal antibody in patients with visual impairment due to pmCNV

  • 0 views
  • 23 Jun, 2021
  • 1 location
Cauterization Versus brin Glue for Conjunctival Autografting in Primary Pterygium Surgery

Pterygium is a noncancerous growth of the conjunctival tissue over the cornea. It is a progressive disease that may lead to visual impairment in advanced stages, as well as restriction of ocular

  • 3 views
  • 22 Jan, 2021
  • 1 location
Mobility Protocol Adapted for Advanced Visually Impaired Subjects

Retinitis Pigmentosa is characterized by a progressive disappearance of photoreceptors, responsible for a progressive and severe loss of vision. People Retinitis Pigmentosa therefore

low vision
  • 0 views
  • 24 Jan, 2021
  • 1 location
Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy

pigment epithelial and photoreceptor damage with visual impairment. The purpose of this clinical study is report the use of intravitreal bevacizumab is a new option in the treatment of

angiography
detachment
fluorescein angiography
bevacizumab
retinal pigment
  • 3 views
  • 07 Nov, 2020
  • 1 location